Danazol is recommended for the treatment of benign fibrocystic breast disease. Symptomatic relief of severe pain and tenderness. Danazol should be used only in patients not responsive to other therapeutic measures or for whom such measures are inadvisable.
For this indication, competent medicine agencies globally authorize below treatments:
100 - 400 mg
From 50 To 200 mg 2 time(s) per day every day
In benign fibrocystic breast disease, treatment should commence at a dose of 300mg daily, a course of treatment normally lasting 3 to 6 months.